ZELTIQ Aesthetics (ZLTQ) Reports Strong Prelim. Q4, FY15 Revenue Numbers

ZELTIQ (NASDAQ: ZLTQ) announced preliminary unaudited revenue for the fourth quarter and full year 2015.

ZELTIQ anticipates total revenue for the fourth quarter 2015 of approximately $78 million, compared to total net revenue for the fourth quarter 2014 of $50.8 million. Fourth quarter 2015 revenue includes add-on applicator revenue of approximately $12 million. ZELTIQ anticipates total revenue for the full year 2015 to be approximately $255 million, compared to total net revenue for the full year 2014 of $174.5 million.

*** Consensus estimates call for revenue of $74.9 million and FY15 revenue of $252 million.

ZELTIQ also announced the launch of a new CoolMini-only system, providing physicians with the option to purchase a system that only comes with the CoolMini applicator which was specifically designed to treat smaller pockets of fat, including the submental fat area, or "double chin." ZELTIQ will begin offering this new configuration in the first quarter of 2016, enabling it to target physicians that primarily or exclusively focus on facial aesthetic treatments. The system can be upgraded with the purchase of additional software and applicators from ZELTIQ. With these individually purchased upgrades, the system has the ability to treat other body areas. Additionally, ZELTIQ has reduced the CoolMini treatment time to 45 minutes due to recent advances in the technology.

Mark Foley, President and Chief Executive Officer, said, "Our preliminary fourth quarter and full year 2015 results continue to demonstrate the strength of our cooling technology and continued leadership in the global non-invasive fat-reduction market. Our fourth quarter results cap off a very successful 2015 in which we generated approximately 46% year-over-year revenue growth which is our 3rd consecutive year of over 45% annual growth. I am incredibly proud of our performance given the significant revenue we generated last year and the challenging comparison it created for us as we entered 2015. Robust growth in the quarter was driven by strong system placements, increasing utilization in both North America and International, and the launch of our new CoolMini applicator. In North America, we sold approximately 240 systems in the fourth quarter, nearly 20% higher on a year-over-year basis when excluding Ideal Image. Additionally, system ASPs remained strong and we saw the continued trend of both existing and new accounts deciding to purchase more than one system resulting in approximately 37% or 90 multi-system placements in North America in the fourth quarter of which approximately 30 were sold to new accounts. We sold over 273,000 cycles in the quarter which represents 57% year-over-year growth and utilization on a per account basis was also very strong with North America utilization growing over 10% and International utilization growing over 15% on a year-over-year basis. We believe that our continued success in placing new systems and growing utilization can be attributed to our reproducible clinical outcomes, value proposition, industry-leading marketing programs, and to the large and underpenetrated non-invasive fat reduction market which is capable of supporting multiple players. Although our CoolMini applicator has only been on the market for a few months, the demand and feedback has been very positive. During the fourth quarter we sold nearly 1,400 CoolMini applicators, as clinicians embraced our revolutionary approach to reduce unwanted fat in the submental area with a comfortable procedure that delivers cost-effective results in 1-2 treatments with little, to no, downtime. Combined with the introduction of our CoolMini-only system, we believe that our CoolMini applicator will help us both grow the non-invasive fat reduction market while also providing a compelling option for facially-focused physicians. We are excited about the early momentum that CoolMini is creating and we expect this to continue into 2016."

Mr. Foley concluded, "Looking ahead, I am very optimistic about our near and long term growth initiatives. In addition to the continued rollout of CoolMini and launching of our new stand-alone CoolMini system, I am excited about our recently announced Galderma partnership, launch of our national Direct-to-Consumer campaign and our upcoming introduction of shorter treatment time applicators. Also, we continue to make infrastructure investments intended to better position us to expand our international presence and lower our effective tax rate. Longer term, we remain committed to further expanding our leadership position through investment in additional applicators, increased brand awareness, and innovative products for the treatment of cellulite and acne. Taken together, these efforts and investments lead us to a full year 2016 revenue expectation of approximately $315 million and give us increased confidence in our long term financial outlook of greater than 20% revenue CAGR through 2019 and a 25%-30% adjusted EBITDA margin at scale."

The quarterly and annual financial numbers included in this release are prior to the completion of review and audit procedures by ZELTIQ's external auditors and are therefore subject to adjustment. ZELTIQ expects to provide full year 2015 financial results and full year 2016 guidance during its fourth quarter 2015 earnings call estimated to be near the end of February 2016.

ZELTIQ announced unaudited preliminary estimates in advance of the J.P. Morgan Healthcare Conference, where President and Chief Executive Officer, Mark Foley, will present at 7:30 a.m. PST / 10:30 a.m. EST on Wednesday, January 13, 2016. The presentation for this event and additional supplemental financial information is currently available online at ZELTIQ's corporate website, www.zeltiq.com, under Investor Relations. A live webcast of the presentation will also be available on ZELTIQ's corporate website. After the live webcast, the presentation will remain available on the website at least until ZELTIQ announces its definitive full year 2015 financial results.

Key Fourth Quarter Operational Information

• Revenue of ~$78 million
  • Add-on Applicator revenue ~$12 million
  • International ~22% of total revenue
  • Consumables ~45% of total revenue (~53% excluding Add-on Applicator revenue)
• ~385 systems shipped globally
  • ~240 North America systems, up ~20% YoY excluding Q4'14 Ideal Image
    • ~90 multi-system placements with ~30 to new accounts
  • ~145 International, up ~61% YoY
• ~150 new accounts opened in North America, up ~6% YoY excluding Q4'14 Ideal Image

• ~273,000 revenue cycles shipped globally
  • ~191,000 North America
  • ~82,000 International
• Global revenue cycle utilization up ~11% per account per day YoY
  • North America utilization up ~10% YoY
  • International utilization up ~15% YoY

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• KeyBanc Reiterates Overweight Rating on Darden Restaurants (DRI)
• Bernstein SocGen's Thoughts on McDonald's (MCD) Following Investor Day